Adhikara, Imam Manggalya
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Hubungan Hipertensi Terhadap Kematian Pasien Covid-19 Dengan Diabetes Melitus Tipe 2 di RSUP dr. Sardjito Fadhilah, Farah; Susanti, Vina Yanti; Nugroho, Dhite Bayu; Adhikara, Imam Manggalya; Handajani, Fitri
CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal Vol. 4 No. 3 (2024): Februari
Publisher : Perhimpunan Dokter Kedokteran Komunitas dan Kesehatan Masyarakat Indonesia (PDK3MI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37148/comphijournal.v4i3.199

Abstract

Diabetes mellitus and hypertension are co-morbidities that are often found in COVID-19 patients. Diabetes can reduce the body's immunity and increase the rate of viral replication, and is associated with vascular problems. Hypertension is one of the comorbid diabetes with high morbidity and mortality. To determine the relationship between hypertension and the death of COVID-19 patients with type 2 diabetes mellitus at Dr Sardjito General Hospital. Observational study with a retrospective cohort study design, using COVID-19 registry data at Dr Sardjito General Hospital for the period March 2020-July 2021. COVID-19 patients with type 2 diabetes mellitus who had hypertension and those who did not have hypertension were selected at Dr Sardjito General Hospital and Collected data on mortality, age, sex, other comorbidities, severity and length of stay. Data were processed using SPSS, in univariate, bivariate, and multivariate analysis models. the results of multivariate analysis using logistic regression found that hypertension, age, and ischemic heart disease did not have a significant association with the death of COVID-19 patients with type 2 diabetes mellitus. The variable that had the greatest power as a predictor of death in COVID-19 patients with diabetes mellitus type 2 is ARDS with a risk of death 20.8 times higher than without ARDS. Patients with kidney failure are at risk of dying 2.7 times higher than those without kidney failure. The addition of length of stay (LOS) 1 day of treatment reduces the risk of death by 16.3%. Hypertension has no significant relationship as a predictor of death in COVID-19 patients with type 2 diabetes mellitus at Dr Sardjito General Hospital. Significant predictors of death in this study were ARDS, kidney failure, and were associated with length of stay (LOS).  
Simplified AHA/ACC ASCVD risk score implementation in a community-driven approach to initiate statin primary prevention Adhikara, Imam Manggalya; Noviana, Uki; Thahadian, Harik Firman; Putra, Yasjudan Rastrama; Handayaningsih, Anastasia Evi; Adyarini, Dwita Dyah; Akhmadi, Akhmadi; Sujalmo, Puwardi; Widyaningsih, Andhika; Rachmawati, Annisa; Rahman, Rahma Azzalia; Meirizka, Fathina; Anggraeni, Vita Yanti
Journal of Community Empowerment for Health Vol 8, No 1 (2025)
Publisher : Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22146/jcoemph.99182

Abstract

Introduction: One of the objectives of the third Sustainable Development Goal is to lower the prevalence of non-communicable diseases (NCD). Cardiovascular disease (CVD) is one of the NCDs that remains the primary cause of mortality in Indonesia and the rest of the world. The most common CVD is coronary artery disease (CAD). It is crucial to perform risk factor assessments on individuals to facilitate early intervention and prevention. A simple instrument to stratify the population's CVD risk factor is the atherosclerotic cardiovascular disease (ASCVD) Risk Score. This study aims to determine the CAD risk stratification through screening using the ASCVD Risk Score in the Sumberadi, Mlati, Sleman, Yogyakarta populations.Methods: A descriptive study screening for CAD was conducted in a population of Sumberadi aged >15 years, especially aged 40-75 years old. The instrument used in this study was the simplified ASCVD Risk Score. The risk factors for CAD, including blood pressure, blood glucose, and cholesterol, were measured with Indonesian-standard instruments. Data was collected by Posbindu cadres with the aid of the research team. Data was analyzed univariately and presented in the form of a descriptive table.Results: This study's sample is mainly female (87%), and the age average is 48.4 ± 9.6 years old. The samples mostly have normal random blood glucose(RBG) levels (82.6%) with a mean of 117.9 ± 55.2 mg/dL. Meanwhile, the total cholesterol level of the samples is mainly normal (51.6%) with a mean of 201.4 ± 40.2 mg/dL. Four samples of people aged>75 years old needed expert consultation. The remaining 403 samples were classified based on the statin requirements (no statin required, moderate-intensity statin, and high-intensity statin). The 148 samples require moderate-intensity statin, and 64 require high-intensity statin.Conclusion: Half of the subjects in this study were included in the statin-required group. And none of them received statin as CAD primary prevention strategy. Most CAD risk factors are conditions that have no symptoms and remain neglected in the population. Therefore, screening CAD risk in the population with simple and easy instruments is still needed to detect individual CAD-risk profiling early. The screening program enables delegates to the Posbindu's cadres who the expertise had trained.